Anthem, Inc. (ANTM)
(Delayed Data from NYSE)
$261.70 USD
+0.11 (0.04%)
Updated May 3, 2019 04:00 PM ET
After-Market: $261.69 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$261.70 USD
+0.11 (0.04%)
Updated May 3, 2019 04:00 PM ET
After-Market: $261.69 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Anthem (ANTM) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Anthem's (ANTM) second-quarter results are likely to reflect impressive revenues and rising membership.
What's in the Cards for Centene's (CNC) Q2 Earnings?
by Zacks Equity Research
Centene's (CNC) Q2 results are likely to reflect better revenues, partly offset by the COVID-19 impact.
Top Ranked Growth Stocks to Buy for July 24th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, July 24th
Universal Health (UHS) to Report Q2 Earnings: What to Expect
by Zacks Equity Research
Universal Health's (UHS) second-quarter results are likely to reflect muted revenues.
Is Anthem (ANTM) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Anthem (ANTM) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Anthem (ANTM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
HCA Healthcare's (HCA) Q2 Earnings Beat Estimates, Fall Y/Y
by Zacks Equity Research
HCA Healthcare's (HCA) second-quarter results reflect lower expenses, partly offset by a decline in admissions.
Top Ranked Growth Stocks to Buy for July 20th
by Zacks Equity Research
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, July 20th
What's in Store for HCA Healthcare's (HCA) Q2 Earnings?
by Zacks Equity Research
HCA Healthcare's (HCA) second-quarter results are likely to reflect dented revenues due to the pandemic woes.
Quest Diagnostics (DGX) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Quest Diagnostics (DGX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
UnitedHealth's (UNH) Earnings in Q2 Beat on Lower Payouts
by Zacks Equity Research
UnitedHealth's (UNH) Q2 earnings outperformance is driven by a temporary postponement of care in the company's risk-based businesses amid the plaguing pandemic .
The Zacks Analyst Blog Highlights: Etsy, TMobile US, Anthem, Novavax and Southwest Gas
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Etsy, TMobile US, Anthem, Novavax and Southwest Gas
Top Ranked Growth Stocks to Buy for July 14th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, July 14th.
6 Health Insurance Stocks Poised to Beat on Earnings in Q2
by Sapna Bagaria
Health insurers' second-quarter 2020 earnings results are likely to gain from lower healthcare utilization, partly offset by higher costs.
Coronavirus to Cast a Pall Over Q2 Earnings: 5 Stocks to Stand Out
by Tirthankar Chakraborty
It will be prudent to invest in companies from the tech, healthcare and utility sectors, which are expected to have suffered less compared to others in Q2.
Top Ranked Growth Stocks to Buy for July 13th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, July 13th
Will Walmart's (WMT) Foray in Health Insurance be a Bane?
by Zacks Equity Research
Walmart's (WMT) penetration in the health insurance industry may intensify competition in the profitable MA market.
3 GARP MedTech Stocks to Beat Pandemic-Led Market Volatility
by Trina Mukherjee
Here we look at three stocks that investors can add to their watchlist backed by robust long-term prospects.
3 Affordable MedTech Growth Stocks to Buy Amid Market Unrest
by Debanjana Dey
Here are some MedTech stocks which might be a solid investment option amid the coronavirus-battered market conditions.
Top Ranked Growth Stocks to Buy for July 8th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, July 8th
Are Investors Undervaluing Anthem (ANTM) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
3 Health Insurers Poised for a Bull Run in the Second Half
by Srijita Guha
We shortlist three health insurance stocks for the second half of 2020 that should enhance your portfolio, given their solid fundamentals.
Here's Why You Should Retain Humana (HUM) in Your Portfolio
by Zacks Equity Research
Riding high on its robust Medicare business line and strategic initiatives, Humana (HUM) holds potential to reap benefits for investors.
Centene vs. Anthem: Which is a Better-Positioned Stock?
by Zacks Equity Research
Centene (CNC) and Anthem (ANTM) are poised to grow in the thriving health insurance industry. On comparative evaluation, we try to discover which is a more profitable bet based on fundamentals.
Anthem (ANTM) Introduces Digital Tools to Help Shareholders
by Zacks Equity Research
Anthem (ANTM) launches a slew of digital tools to allow stakeholders to make informed choices under current difficult circumstances.